DENVER — Inocucor, the agri-tech company that produces biological crop inputs for row crops and high-value produce, has added two agriculture bioscience leaders, Carole Cobb and Gregg Bogosian, Ph.D., to its Manufacturing Advisory Board.
Under the direction of Board Chair Jeff Lievense, Ph.D., one of the world's leading experts on fermentation process engineering, the independent advisory team will assist in the design of Inocucor's new production facility at its 30,000-square-foot U.S. headquarters and commercialization office in Centennial, Colo. It also will offer expertise as Inocucor scales up its process development and pilot manufacturing capabilities at the company’s Technical Center of Excellence, a 20,000-square-foot facility in Montreal.
Cobb is COO of GreenLight BioSciences and has over 30 years' experience in industrial biotechnology, worldwide manufacturing, technology acquisition, global supply chain and start-ups. She has overseen numerous fermentation-based manufacturing plants in the U.S., Europe, China and South America, as well as three major warehouse/distribution centers. She holds an MBA in Finance from the University of Rochester and a B.S. in Chemical Engineering, Biochemistry, and Cell and Molecular Biology from the State University of New York at Buffalo.
Bogosian is a consultant with more than 35 years' experience in biotechnology, specializing in the use of fermentation to produce microbial products. He is experienced in cGMP-compliant manufacturing of biologicals. Bogosian holds a Ph.D. in Biochemistry from Purdue University and has completed postdoctoral studies in Microbiology at the University of North Carolina at Chapel Hill. He earned a B.A. in Zoology at Miami University.
Inocucor uses a patented fermentation process to combine multi-strains of bacteria and yeasts into powerful soil and plant optimizers that are safe for people and the environment. These products naturally improve crop yields, shorten growing periods and create healthier, more resilient soils for farmers and greenhouse growers.
Inocucor recently completed the $38.8 million CAD ($29 million USD) first close of its Series B financing round, with lead investor TPG Alternative and Renewable Technologies (San Francisco) and participation from Cycle Capital Management (Quebec), Desjardins Innovatech (Quebec) and Closed Loop Capital (U.S.).